Home   Contact Us   Sitemap
 

 Financial & IR Update  News Update  Annual Report 2013-14
 
Indoco Remedies Q2 Profit After Tax (PAT) grows by 40% - Q2 FY15
Unaudited Standalone Financial Results for the Quarter and Half Year ended 30th September, 2014 - Q2 FY15
Management Discussion & Analysis - Q2 FY15
 
Indoco Remedies gets USFDA nod for Goa's sterile and solid dosage facilities - July 21, 2014
We will reach Rs 1,000-crore sales in a year-and-a-half - May 13, 2014
Mr. Suresh G. Kare's 50 glorious years of visionary leadership at Indoco - July 02, 2013
more »